Copyright
©The Author(s) 2021.
World J Gastrointest Oncol. Dec 15, 2021; 13(12): 2161-2179
Published online Dec 15, 2021. doi: 10.4251/wjgo.v13.i12.2161
Published online Dec 15, 2021. doi: 10.4251/wjgo.v13.i12.2161
Figure 1 Tumor regression grading according to 15th Japanese Classification of Gastric Carcinoma criteria.
A: Grade 3 (complete regression); B: Grade 2b (5% residual tumor); C: Grade 2a (30% residual tumor); D: Grade 1b (50% residual tumor); E: Grade 1a (70% residual tumor); F: Grade 0 (No response) (original magnification 20×).
Figure 2
Selection of patients for inclusion.
Figure 3 Kaplan-Meier curves for overall survival of five tumor regression grade systems.
A: JGCA2017-tumor regression grade (TRG); B: JGCA-TRG; C: Becker-TRG; D: AJCC/CAP-TRG; E: Mandard; F: Rearranged cutoff values. P value stands for log-rank test.
Figure 4 Kaplan-Meier curves for progression-free survival of five tumor regression grade systems.
A: JGCA2017-tumor regression grade (TRG); B: JGCA-TRG; C: Becker-TRG; D: AJCC/CAP-TRG; E: Mandard; F: Rearranged cutoff values. P value stands for log-rank test.
- Citation: Liu ZN, Wang YK, Zhang L, Jia YN, Fei S, Ying XJ, Zhang Y, Li SX, Sun Y, Li ZY, Ji JF. Comparison of tumor regression grading systems for locally advanced gastric adenocarcinoma after neoadjuvant chemotherapy. World J Gastrointest Oncol 2021; 13(12): 2161-2179
- URL: https://www.wjgnet.com/1948-5204/full/v13/i12/2161.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v13.i12.2161